Millipore Sigma Vibrant Logo

OP76 Anti-p21WAF1 (Ab-4) Mouse mAb (65)

FDS (Fiches de données de sécurité), certificats d’analyse (CoA) et de qualité (CoQ), dossiers, brochures et autres documents disponibles.

Synonymes: Anti-CIP1, Anti-SD11, Anti-p21, Anti-WAF

View Products on Sigmaaldrich.com
OP76
  
Prix en cours de récupération
Le prix n'a pas pu être récupéré
La quantité minimale doit être un multiple de
Maximum Quantity is
À la validation de la commande Plus d'informations
Vous avez sauvegardé ()
 
—
Demander le prix
—
Disponibilité limitée Disponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Contact Customer Service

       

      Contacter le Service Clients

      Aperçu

      Replacement Information

      Tableau de caractéristiques principal

      Species ReactivityHostAntibody Type
      M, RMMonoclonal Antibody
      Description
      Overview

      This product has been discontinued.



      Recognizes the ~21 kDa p21WAF1 protein in rat and mouse embryo fibroblast cell lines treated with actinomycin D.
      Catalogue NumberOP76
      Brand Family Calbiochem®
      SynonymsAnti-CIP1, Anti-SD11, Anti-p21, Anti-WAF
      References
      ReferencesAgarwal, M.L., et al. 1995. Proc. Natl. Acad. Sci. USA 92, 8493.
      Chen, Y.Q., et al. 1995. Int. J. Oncology 7, 889.
      Deng, C., et al. 1995. Cell 82, 675.
      El-Deiry, W.S., et al. 1995. Cancer Res. 55, 2910.
      Waldman, T., et al. 1995. Cancer Res. 55, 5187.
      Elbendary, A., et al. 1994. Cell Growth Diff. 5, 1301.
      El-Deiry, W.S., et al. 1994. Cancer Res. 54, 1169.
      Li, R., et al. 1994. Nature 371, 534.
      Michieli, P., et al. 1994. Cancer Res. 54, 3391.
      Noda, A., et al. 1994. Exp. Cell Res. 211, 90.
      El-Deiry, W.S., et al. 1993. Cell 75, 817.
      Gu, Y., et al. 1993. Nature 366, 707.
      Harper, J.W., et al. 1993. Cell 75, 805.
      Xiong, Y., et al. 1993. Nature 366, 701.
      Xiong, Y., et al. 1993. Genes Devel. 7,1572.
      Xiong, Y., et al. 1992. Cell 71, 505.
      Product Information
      FormLiquid
      FormulationIn 50 mM sodium phosphate buffer, 0.2% gelatin.
      Positive controlRat or mouse embryo fibroblast cell lines treated with Actinomycin D (Cat. No. 114666)
      Preservative≤0.1% sodium azide
      Quality LevelMQ100
      Applications
      Application ReferencesEpitope Identification O'Connor. P., NCI, personal communication
      Key Applications Immunoblotting (Western Blotting)
      Immunoprecipitation
      Application NotesImmunoblotting (3 µg/ml, chemiluminescence)
      Immunoprecipitation (2 µg/sample)
      Application CommentsMaximal p21 WAF1 expression requires wild type p53 activity. Treatment of mouse or rat embryo fibroblasts with DNA damaging agents such as actinomycin D induces wild type p53 expression which in turn activates WAF1 expression. Serum stimulation of quiescent cells will give low level WAF1 expression independent of p53 expression. This antibody can co-precipitate proteins associated with WAF1. Antibody should be titrated for optimal results in individual systems.
      Biological Information
      Immunogenrecombinant, mouse p21WAF1
      ImmunogenMouse
      Epitopewithin amino acids 90-109 of mouse p21WAF1
      Clone65
      HostMouse
      IsotypeIgG₁
      Species Reactivity
      • Mouse
      • Rat
      Antibody TypeMonoclonal Antibody
      Concentration Label Please refer to vial label for lot-specific concentration
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Blue Ice Only
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Do not freeze Yes
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Référence GTIN
      OP76 0

      Documentation

      Anti-p21WAF1 (Ab-4) Mouse mAb (65) FDS

      Titre

      Fiche de données de sécurité des matériaux (FDS) 

      Anti-p21WAF1 (Ab-4) Mouse mAb (65) Certificats d'analyse

      TitreNuméro de lot
      OP76

      Références bibliographiques

      Aperçu de la référence bibliographique
      Agarwal, M.L., et al. 1995. Proc. Natl. Acad. Sci. USA 92, 8493.
      Chen, Y.Q., et al. 1995. Int. J. Oncology 7, 889.
      Deng, C., et al. 1995. Cell 82, 675.
      El-Deiry, W.S., et al. 1995. Cancer Res. 55, 2910.
      Waldman, T., et al. 1995. Cancer Res. 55, 5187.
      Elbendary, A., et al. 1994. Cell Growth Diff. 5, 1301.
      El-Deiry, W.S., et al. 1994. Cancer Res. 54, 1169.
      Li, R., et al. 1994. Nature 371, 534.
      Michieli, P., et al. 1994. Cancer Res. 54, 3391.
      Noda, A., et al. 1994. Exp. Cell Res. 211, 90.
      El-Deiry, W.S., et al. 1993. Cell 75, 817.
      Gu, Y., et al. 1993. Nature 366, 707.
      Harper, J.W., et al. 1993. Cell 75, 805.
      Xiong, Y., et al. 1993. Nature 366, 701.
      Xiong, Y., et al. 1993. Genes Devel. 7,1572.
      Xiong, Y., et al. 1992. Cell 71, 505.
      Fiche technique

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision03-October-2007 RFH
      SynonymsAnti-CIP1, Anti-SD11, Anti-p21, Anti-WAF
      ApplicationImmunoblotting (3 µg/ml, chemiluminescence)
      Immunoprecipitation (2 µg/sample)
      DescriptionPurified mouse monoclonal antibody. Recognizes ~21 kDa p21WAF1 protein.
      BackgroundThe tumor suppressor p53 transcriptionally activates a number of genes including the WAF1/CIP1 gene in response to DNA damage. The 21 kDa product of the WAF1 gene is found in a complex involving cyclins, cyclin dependent kinases (CDK), and PCNA in normal cells but not transformed cells and appears to be a universal inhibitor of CDK activity. One consequence of p21 WAF1 binding to and inhibiting CDKs is to prevent CDK-dependent phosphorylation and subsequent inactivation of the Rb protein which is essential for cell cycle progression. p21 WAF1 is, therefore, a potent and reversible inhibitor of cell cycle progression at both the G1 and G2 checkpoints (2,3,9), presumably to allow sufficient time for DNA repair to be completed. Irreversible G1 or G2 arrest leads to apoptosis. However, the role of p21 WAF1 in apoptosis is less clear although p53-mediated apoptosis leads to increased WAF1 expression. Induction of p21 WAF1 in response to DNA damage can occur by both p53-dependent and p53-independent mechanisms, in response to mitogenic stimuli, differentiation, or in tumor cells with mutated p53. Functional p21 WAF1 is essential for p53-mediated G1 arrest presumably due to WAF1 inhibition of both CDK activity and PCNA-dependent DNA replication. WAF1 has also been identified as a gene involved in cellular senescence, termed sdi1. Not surprisingly, p21 WAF1 overexpression is growth suppressive consistent with its role as an inhibitor of CDKs. By inhibiting Rb inactivation in a p53-dependent fashion, p21 WAF1 serves to integrate cell cycle control mediated by p53 and Rb.
      HostMouse
      Immunogen speciesMouse
      Immunogenrecombinant, mouse p21WAF1
      Epitopewithin amino acids 90-109 of mouse p21WAF1
      Clone65
      IsotypeIgG₁
      Speciesmouse, rat
      Positive controlRat or mouse embryo fibroblast cell lines treated with Actinomycin D (Cat. No. 114666)
      FormLiquid
      FormulationIn 50 mM sodium phosphate buffer, 0.2% gelatin.
      Concentration Label Please refer to vial label for lot-specific concentration
      Preservative≤0.1% sodium azide
      CommentsMaximal p21 WAF1 expression requires wild type p53 activity. Treatment of mouse or rat embryo fibroblasts with DNA damaging agents such as actinomycin D induces wild type p53 expression which in turn activates WAF1 expression. Serum stimulation of quiescent cells will give low level WAF1 expression independent of p53 expression. This antibody can co-precipitate proteins associated with WAF1. Antibody should be titrated for optimal results in individual systems.
      Storage +2°C to +8°C
      Do Not Freeze Yes
      Toxicity Standard Handling
      ReferencesAgarwal, M.L., et al. 1995. Proc. Natl. Acad. Sci. USA 92, 8493.
      Chen, Y.Q., et al. 1995. Int. J. Oncology 7, 889.
      Deng, C., et al. 1995. Cell 82, 675.
      El-Deiry, W.S., et al. 1995. Cancer Res. 55, 2910.
      Waldman, T., et al. 1995. Cancer Res. 55, 5187.
      Elbendary, A., et al. 1994. Cell Growth Diff. 5, 1301.
      El-Deiry, W.S., et al. 1994. Cancer Res. 54, 1169.
      Li, R., et al. 1994. Nature 371, 534.
      Michieli, P., et al. 1994. Cancer Res. 54, 3391.
      Noda, A., et al. 1994. Exp. Cell Res. 211, 90.
      El-Deiry, W.S., et al. 1993. Cell 75, 817.
      Gu, Y., et al. 1993. Nature 366, 707.
      Harper, J.W., et al. 1993. Cell 75, 805.
      Xiong, Y., et al. 1993. Nature 366, 701.
      Xiong, Y., et al. 1993. Genes Devel. 7,1572.
      Xiong, Y., et al. 1992. Cell 71, 505.
      Application referencesEpitope Identification O'Connor. P., NCI, personal communication